{"transactions":[{"id":828051,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":56009,"kind":"person","name":"HUMPHREY RACHEL","position":1,"cik":"0001579781","reported_name":"HUMPHREY RACHEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-25T17:05:57.000Z","date":"2026-03-24","kind":"grant","planned":false,"acquired":true,"shares":45867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":45867,"derivative":{"exercise_price":1.36,"expiration_date":"2036-03-24","underlying":"Common Stock","underlying_shares":45867},"source":{"system":"sec-edgar","filing":"0001193125-26-124319","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579781/000119312526124319/ownership.xml","form_type":"4"}},{"id":828050,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":56009,"kind":"person","name":"HUMPHREY RACHEL","position":1,"cik":"0001579781","reported_name":"HUMPHREY RACHEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-25T16:30:11.000Z","date":"2025-04-21","kind":"sale","planned":true,"acquired":false,"shares":13896,"price":1.0335,"value":14361.516,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects sales of common stock executed in multiple transactions. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected within the ranges set forth in footnotes 3 through 4 of this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $0.97 to $1.09."}],"balance_after":81309,"source":{"system":"sec-edgar","filing":"0000905148-26-001434","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1579781/000090514826001434/form4.xml","form_type":"4"}},{"id":828049,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":56009,"kind":"person","name":"HUMPHREY RACHEL","position":1,"cik":"0001579781","reported_name":"HUMPHREY RACHEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-25T16:30:11.000Z","date":"2025-04-17","kind":"sale","planned":true,"acquired":false,"shares":200,"price":0.97,"value":194.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2024."}],"balance_after":95205,"source":{"system":"sec-edgar","filing":"0000905148-26-001434","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1579781/000090514826001434/form4.xml","form_type":"4"}},{"id":828048,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":56009,"kind":"person","name":"HUMPHREY RACHEL","position":1,"cik":"0001579781","reported_name":"HUMPHREY RACHEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-25T16:30:11.000Z","date":"2025-04-14","kind":"sale","planned":true,"acquired":false,"shares":1400,"price":0.9727,"value":1361.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects sales of common stock executed in multiple transactions. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected within the ranges set forth in footnotes 3 through 4 of this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $0.97 to $0.98."}],"balance_after":95405,"source":{"system":"sec-edgar","filing":"0000905148-26-001434","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579781/000090514826001434/form4.xml","form_type":"4"}},{"id":1182582,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":56009,"kind":"person","name":"HUMPHREY RACHEL","position":1,"cik":"0001579781","reported_name":"HUMPHREY RACHEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock  Option  (Right to  Buy)","published_at":"2025-04-02T09:03:25.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":36979,"price":0.98,"value":36239.42,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":36979,"derivative":{"exercise_price":0.98,"expiration_date":"2035-03-31","underlying":"Common Stock","underlying_shares":36979},"source":{"system":"sec-edgar","filing":"0000950170-25-048901","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579781/000095017025048901/ownership.xml","form_type":"4"}},{"id":1558209,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":56009,"kind":"person","name":"HUMPHREY RACHEL","position":1,"cik":"0001579781","reported_name":"HUMPHREY RACHEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-28T16:32:21.000Z","date":"2024-03-26","kind":"grant","planned":false,"acquired":true,"shares":38741,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":96805,"source":{"system":"sec-edgar","filing":"0000950170-24-038099","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579781/000095017024038099/ownership.xml","form_type":"4"}},{"id":1936524,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":56009,"kind":"person","name":"HUMPHREY RACHEL","position":1,"cik":"0001579781","reported_name":"HUMPHREY RACHEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-28T16:43:44.000Z","date":"2023-03-24","kind":"grant","planned":false,"acquired":true,"shares":58064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":58064,"source":{"system":"sec-edgar","filing":"0001209191-23-021408","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579781/000120919123021408/doc4.xml","form_type":"4"}},{"id":2185306,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":56009,"kind":"person","name":"HUMPHREY RACHEL","position":1,"cik":"0001579781","reported_name":"HUMPHREY RACHEL","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-15T17:44:18.000Z","date":"2022-08-11","kind":"grant","acquired":true,"shares":236220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options vest in three equal annual installments from the grant date, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":236220,"derivative":{"exercise_price":2.91,"expiration_date":"2032-08-11","underlying":"Common Stock","underlying_shares":236220},"source":{"system":"sec-edgar","filing":"0001140361-22-029677","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579781/000114036122029677/form4.xml","form_type":"4"}},{"id":2846341,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":56009,"kind":"person","name":"HUMPHREY RACHEL","position":1,"cik":"0001579781","reported_name":"HUMPHREY RACHEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-19T23:55:27.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to this option shall vest and become exercisable on February 17, 2022, with the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":60000,"derivative":{"exercise_price":28.69,"expiration_date":"2031-02-16","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-21-007440","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000089924321007440/doc4.xml","form_type":"4"}},{"id":3034448,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":56009,"kind":"person","name":"HUMPHREY RACHEL","position":1,"cik":"0001579781","reported_name":"HUMPHREY RACHEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-10T20:56:53.000Z","date":"2020-09-08","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of this option shall vest and become exercisable on September 8, 2021, with the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":150000,"derivative":{"exercise_price":28.14,"expiration_date":"2030-09-08","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000899243-20-024836","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000089924320024836/doc4.xml","form_type":"4"}},{"id":3034447,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":56009,"kind":"person","name":"HUMPHREY RACHEL","position":1,"cik":"0001579781","reported_name":"HUMPHREY RACHEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-09-10T20:56:53.000Z","date":"2020-09-08","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\") granted under the Black Diamond Therapeutics, Inc. 2020 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in three equal annual installments, with the first installment commencing on September 8, 2021, subject to the Reporting Person's continuous service to the Issuer through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\") granted under the Black Diamond Therapeutics, Inc. 2020 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in three equal annual installments, with the first installment commencing on September 8, 2021, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000899243-20-024836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000089924320024836/doc4.xml","form_type":"4"}},{"id":3683579,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":56009,"kind":"person","name":"HUMPHREY RACHEL","position":1,"cik":"0001579781","reported_name":"HUMPHREY RACHEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-30T00:00:03.000Z","date":"2019-01-25","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2019 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":90000,"derivative":{"exercise_price":16.85,"expiration_date":"2029-01-24","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001567619-19-001865","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761919001865/doc1.xml","form_type":"4"}},{"id":4013970,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":56009,"kind":"person","name":"HUMPHREY RACHEL","position":1,"cik":"0001579781","reported_name":"HUMPHREY RACHEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-05T23:59:56.000Z","date":"2018-03-02","kind":"exercise","acquired":false,"shares":16160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests 25% on August 28, 2016, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, with each additional installment vesting on the last day of the month, except the final installment, which shall vest on August 28, 2019."}],"balance_after":222980,"derivative":{"exercise_price":6.6147,"expiration_date":"2025-08-27","underlying":"Common Stock","underlying_shares":16160},"source":{"system":"sec-edgar","filing":"0001140361-18-012113","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118012113/doc1.xml","form_type":"4"}},{"id":4013969,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":56009,"kind":"person","name":"HUMPHREY RACHEL","position":1,"cik":"0001579781","reported_name":"HUMPHREY RACHEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-03-05T23:59:56.000Z","date":"2018-03-02","kind":"sale","acquired":false,"shares":16160,"price":30,"value":484800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":30234,"source":{"system":"sec-edgar","filing":"0001140361-18-012113","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118012113/doc1.xml","form_type":"4"}},{"id":4013968,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":56009,"kind":"person","name":"HUMPHREY RACHEL","position":1,"cik":"0001579781","reported_name":"HUMPHREY RACHEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-03-05T23:59:56.000Z","date":"2018-03-02","kind":"exercise","acquired":true,"shares":16160,"price":6.6147,"value":106893.552,"ownership":{"direct":true},"balance_after":46394,"source":{"system":"sec-edgar","filing":"0001140361-18-012113","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118012113/doc1.xml","form_type":"4"}},{"id":4019311,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":56009,"kind":"person","name":"HUMPHREY RACHEL","position":1,"cik":"0001579781","reported_name":"HUMPHREY RACHEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-02T16:55:45.000Z","date":"2018-02-28","kind":"exercise","acquired":false,"shares":23840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests 25% on August 28, 2016, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, with each additional installment vesting on the last day of the month, except the final installment, which shall vest on August 28, 2019."}],"balance_after":239140,"derivative":{"exercise_price":6.6147,"expiration_date":"2025-08-27","underlying":"Common Stock","underlying_shares":23840},"source":{"system":"sec-edgar","filing":"0001140361-18-011515","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118011515/doc1.xml","form_type":"4"}},{"id":4019310,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":56009,"kind":"person","name":"HUMPHREY RACHEL","position":1,"cik":"0001579781","reported_name":"HUMPHREY RACHEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-03-02T16:55:45.000Z","date":"2018-02-28","kind":"sale","acquired":false,"shares":23840,"price":30,"value":715200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":30234,"source":{"system":"sec-edgar","filing":"0001140361-18-011515","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118011515/doc1.xml","form_type":"4"}},{"id":4019309,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":56009,"kind":"person","name":"HUMPHREY RACHEL","position":1,"cik":"0001579781","reported_name":"HUMPHREY RACHEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-03-02T16:55:45.000Z","date":"2018-02-28","kind":"exercise","acquired":true,"shares":23840,"price":6.6147,"value":157694.448,"ownership":{"direct":true},"balance_after":54074,"source":{"system":"sec-edgar","filing":"0001140361-18-011515","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118011515/doc1.xml","form_type":"4"}},{"id":4087930,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":56009,"kind":"person","name":"HUMPHREY RACHEL","position":1,"cik":"0001579781","reported_name":"HUMPHREY RACHEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-26T21:52:25.000Z","date":"2018-01-24","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2018 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":100000,"derivative":{"exercise_price":25.82,"expiration_date":"2028-01-23","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001140361-18-003419","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118003419/doc1.xml","form_type":"4"}},{"id":4125950,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":56009,"kind":"person","name":"HUMPHREY RACHEL","position":1,"cik":"0001579781","reported_name":"HUMPHREY RACHEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-19T17:23:05.000Z","date":"2017-12-15","kind":"exercise","acquired":false,"shares":15117,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests 25% on August 28, 2016, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, with each additional installment vesting on the last day of the month, except the final installment, which shall vest on August 28, 2019."}],"balance_after":262980,"derivative":{"exercise_price":6.6147,"expiration_date":"2025-08-27","underlying":"Common Stock","underlying_shares":15117},"source":{"system":"sec-edgar","filing":"0001140361-17-046649","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036117046649/doc1.xml","form_type":"4"}},{"id":4125949,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":56009,"kind":"person","name":"HUMPHREY RACHEL","position":1,"cik":"0001579781","reported_name":"HUMPHREY RACHEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-12-19T17:23:05.000Z","date":"2017-12-15","kind":"exercise","acquired":true,"shares":15117,"price":6.6147,"value":99994.4199,"ownership":{"direct":true},"balance_after":30234,"source":{"system":"sec-edgar","filing":"0001140361-17-046649","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036117046649/doc1.xml","form_type":"4"}},{"id":4478848,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":56009,"kind":"person","name":"HUMPHREY RACHEL","position":1,"cik":"0001579781","reported_name":"HUMPHREY RACHEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-27T18:54:01.000Z","date":"2017-01-25","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2017 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":120000,"derivative":{"exercise_price":11.94,"expiration_date":"2027-01-24","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001140361-17-003159","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036117003159/doc1.xml","form_type":"4"}},{"id":4510374,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":56009,"kind":"person","name":"HUMPHREY RACHEL","position":1,"cik":"0001579781","reported_name":"HUMPHREY RACHEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-12-29T20:52:40.000Z","date":"2016-12-28","kind":"exercise","acquired":false,"shares":15117,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests 25% on August 28, 2016, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, with each additional installment vesting on the last day of the month, except the final installment, which shall vest on August 28, 2019."}],"balance_after":278097,"derivative":{"exercise_price":6.6147,"expiration_date":"2025-08-27","underlying":"Common Stock","underlying_shares":15117},"source":{"system":"sec-edgar","filing":"0001140361-16-091061","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036116091061/doc1.xml","form_type":"4"}},{"id":4510373,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":56009,"kind":"person","name":"HUMPHREY RACHEL","position":1,"cik":"0001579781","reported_name":"HUMPHREY RACHEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2016-12-29T20:52:40.000Z","date":"2016-12-28","kind":"exercise","acquired":true,"shares":15117,"price":6.6147,"value":99994.4199,"ownership":{"direct":true},"balance_after":15117,"source":{"system":"sec-edgar","filing":"0001140361-16-091061","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036116091061/doc1.xml","form_type":"4"}}]}